Skip to main content

D. E. Shaw & Co., Inc.

Position in SMMT — Summit Therapeutics Inc.

CIK 1009207 New York, NY

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,118,610
-$24,394,051 QoQ
Shares Held
1,243,556
-44.5% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 242 holders
Holding Since
Jun 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Dec 31, 2024
CallValue
$981,475
CallShares
55,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. SMMT ranks #54 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SMMT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,118,610 1,243,556
2026-03-31 $42,512,661 2,242,229
2025-12-31 $7,263,317 415,284
2025-09-30 $2,698,753 130,627
2025-06-30 $2,924,829 137,445
2025-03-31 $574,436 29,779
2024-12-31 $981,475 55,000
2024-12-31 $642,794 36,021
2024-09-30 $8,807,457 402,167
2024-06-30 $231,660 29,700
2021-12-31 $40,742 15,146
2021-09-30 $115,981 23,150
2021-06-30 $75,808 10,162